$CFB
CrossFirst Bankshares Inc Stock $cfb

$cfb Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000156276222000212 Filed on May 05, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$47.76M	$48.15M
YoY Change	-0.82%	-11.17%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.241M	$1.380M
YoY Change	-10.07%	6.15%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$4.645M	$7.036M
YoY Change	-33.98%	-55.97%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$21.02M	$14.94M
YoY Change	40.67%	260.0%
Income Tax	$4.188M	$2.908M
% Of Pretax Income	19.93%	19.46%
Net Earnings	$16.83M	$12.04M
YoY Change	39.83%	212.03%
Net Earnings / Revenue	35.23%	24.99%
Basic Earnings Per Share	$0.33	$0.23
Diluted Earnings Per Share	$330.5K	$0.23
COMMON SHARES
Basic Shares Outstanding	50.25M shares	51.66M shares
Diluted Shares Outstanding	50.91M shares	52.38M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$276.9M	$630.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$88.80M	$69.27M
YoY Change	28.19%	0.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$5.518B	$5.998B
YoY Change	-8.0%	18.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.62M	$30.30M
YoY Change	-35.25%	-24.44%
Accrued Expenses	$26.00M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt		$3.300M
YoY Change		-91.52%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$45.62M	$30.30M
YoY Change	50.56%	-24.44%
LONG-TERM LIABILITIES
Long-Term Debt	$1.022M	$1.000M
YoY Change	2.2%	11.11%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$1.022M	$1.000M
YoY Change	2.2%	11.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$45.62M	$30.30M
Total Long-Term Liabilities	$1.022M	$1.000M
Total Liabilities	$4.895B	$5.369B
YoY Change	-8.83%	20.51%
SHAREHOLDERS EQUITY
Retained Earnings		$89.72M
YoY Change		30.62%
Common Stock		$523.0K
YoY Change		0.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$7.113M
YoY Change
Treasury Stock Shares	3.198M shares	698.1K shares
Shareholders Equity	$623.2M	$628.8M
YoY Change
Total Liabilities & Shareholders Equity	$5.518B	$5.998B
YoY Change	-8.0%	18.37%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	$16.83M	$12.04M
YoY Change	39.83%	212.03%
Depreciation, Depletion And Amortization	$1.241M	$1.380M
YoY Change	-10.07%	6.15%
Cash From Operating Activities	$14.49M	-$9.735M
YoY Change	-248.79%	-176.84%
INVESTING ACTIVITIES
Capital Expenditures	$962.0K	$118.0K
YoY Change	715.25%	-64.35%
Acquisitions
YoY Change
Other Investing Activities	-$130.2M	-$114.6M
YoY Change	13.64%	-27.05%
Cash From Investing Activities	-$131.2M	-$114.7M
YoY Change	14.37%	-27.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$16.59M	$1.052M
YoY Change	1477.19%	-105300.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$89.12M	$346.4M
YoY Change	-125.73%	197.63%
NET CHANGE
Cash From Operating Activities	$14.49M	-$9.735M
Cash From Investing Activities	-$131.2M	-$114.7M
Cash From Financing Activities	-$89.12M	$346.4M
Net Change In Cash	-$205.8M	$222.0M
YoY Change	-192.71%	-883.46%
FREE CASH FLOW
Cash From Operating Activities	$14.49M	-$9.735M
Capital Expenditures	$962.0K	$118.0K
Free Cash Flow	$13.52M	-$9.853M
YoY Change	-237.25%	-179.85%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001458412
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-39028
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	CROSSFIRST BANKSHARES, INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	KS
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-3212879
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	11440 Tomahawk Creek Parkway
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Leawood
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	KS
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	66211
CY2022Q1	dei	City Area Code CityAreaCode	913
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	312-6822
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2022Q1	dei	Trading Symbol TradingSymbol	CFB
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	628834000	USD
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49645914	shares
CY2022Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	4349568000	USD
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	4256213000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	55231000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	58375000	USD
CY2022Q1	us-gaap	Notes Receivable Net NotesReceivableNet	4294337000	USD
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	4197838000	USD
CY2022Q1	us-gaap	Time Deposits TimeDeposits	512067000	USD
CY2022Q1	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	226600000	USD
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	3198302	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2139970	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	623199000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	667573000	USD
CY2022Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-625000	USD
CY2021Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	7500000	USD
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-103000	USD
CY2021Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-39000	USD
CY2022Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	388000	USD
CY2021Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	416000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	2655000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	0	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax	653000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax	0	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	2002000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	0	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-404000	USD
CY2021Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1052000	USD
CY2021Q1	cfb	Adjustments To Additional Paid In Capital Employee Receivables From Sale Of Stock AdjustmentsToAdditionalPaidInCapitalEmployeeReceivablesFromSaleOfStock	35000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	649000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	667573000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-617000	USD
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	16762000	USD
CY2022Q1	cfb	Adjustments To Additional Paid In Capital Employee Receivables From Sale Of Stock AdjustmentsToAdditionalPaidInCapitalEmployeeReceivablesFromSaleOfStock	6000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1115000	USD
CY2022Q1	cfb	Exercise Of Warrants Value Of Shares Issued ExerciseOfWarrantsValueOfSharesIssued	167000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	623199000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	16828000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	12035000	USD
CY2022Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	1241000	USD
CY2021Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	1375000	USD
CY2022Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-625000	USD
CY2021Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	7500000	USD
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1116000	USD
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1310000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1115000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	649000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3358000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1824000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-26000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	10000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	910000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	751000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-14115000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	28730000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-21779000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-4937000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14485000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9735000	USD
CY2022Q1	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	94437000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	74947000	USD
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	49138000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	74575000	USD
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	11582000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	33329000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	237000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	0	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	962000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	118000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	13000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	1544000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	1626000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-131161000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-114685000	USD
CY2022Q1	cfb	Increase Decrease In Demand Deposits Savings Now And Money Market Accounts IncreaseDecreaseInDemandDepositsSavingsNOWAndMoneyMarketAccounts	50403000	USD
CY2021Q1	cfb	Increase Decrease In Demand Deposits Savings Now And Money Market Accounts IncreaseDecreaseInDemandDepositsSavingsNOWAndMoneyMarketAccounts	468521000	USD
CY2022Q1	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	-112320000	USD
CY2021Q1	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	-111691000	USD
CY2022Q1	us-gaap	Increase Decrease In Federal Funds Purchased And Securities Sold Under Agreements To Repurchase Net IncreaseDecreaseInFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchaseNet	0	USD
CY2021Q1	us-gaap	Increase Decrease In Federal Funds Purchased And Securities Sold Under Agreements To Repurchase Net IncreaseDecreaseInFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchaseNet	988000	USD
CY2022Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	10000000	USD
CY2021Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	10000000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	170000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2022Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	172000	USD
CY2021Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	16762000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1052000	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	793000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	404000	USD
CY2022Q1	cfb	Increase Decrease In Employee Receivables IncreaseDecreaseInEmployeeReceivables	6000	USD
CY2021Q1	cfb	Increase Decrease In Employee Receivables IncreaseDecreaseInEmployeeReceivables	35000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-89124000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	346397000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-205800000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	221977000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	482727000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	408810000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	630787000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	4784000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	7287000	USD
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	130000	USD
CY2022Q1	cfb	Number Of Subsidiaries NumberOfSubsidiaries	3	Item
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div id="TextBlockContainer13" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:731px;height:128px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2805" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Use of Estimates </div><div id="a2808" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:41px;top:39px;">The Company identified accounting policies and estimates that, due<div style="display:inline-block;width:5px"> </div>to the difficult, subjective or complex judgments and </div><div id="a2810" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:57px;">assumptions inherent in those policies and estimates and the potential sensitivity<div style="display:inline-block;width:5px"> </div>of the Company’s financial statements to those </div><div id="a2812" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:75px;">judgments and assumptions, are critical to an understanding of the<div style="display:inline-block;width:5px"> </div>Company’s financial condition and results of operations. Actual </div><div id="a2814" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:94px;">results could differ from those estimates. The allowance for credit losses, deferred<div style="display:inline-block;width:5px"> </div>tax asset, and fair value of financial instruments are </div><div id="a2818" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:112px;">particularly susceptible to significant change.</div></div>
CY2022Q1	us-gaap	Cash And Securities Segregated Under Federal And Other Regulations CashAndSecuritiesSegregatedUnderFederalAndOtherRegulations	182000000	USD
CY2022Q1	us-gaap	Cash Reserve Deposit Required And Made CashReserveDepositRequiredAndMade	0	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<div id="TextBlockContainer28" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:745px;height:598px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_24_XBRL_TS_9ecf327da388482592789fe77a6239dc" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer25" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:672px;height:38px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2869" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;color:#000000;left:5px;top:0px;">ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement<div style="display:inline-block;width:2px"> </div>of Credit Losses on Financial </div><div id="a2875" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;color:#000000;left:5px;top:20px;">Instruments:</div></div></div><div id="div_26_XBRL_TS_4695c5c78bc046e2828f6d38a4186e84" style="position:absolute;left:37px;top:61px;float:left;"><div id="TextBlockContainer27" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:707px;height:537px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2879" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Background</div><div id="a2880" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:74px;top:0px;"><div style="display:inline-block;width:3px"> </div>– ASU 2016-13 and its subsequent amendments provide new guidance on the impairment model for financial assets </div><div id="a2888" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:18px;">measured at amortized cost, including loans held-for-investment and<div style="display:inline-block;width:5px"> </div>off-balance sheet credit exposures. The Current Expected </div><div id="a2900" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:37px;">Credit Loss (“CECL”) model requires an estimate of expected credit losses, measured<div style="display:inline-block;width:5px"> </div>over the contractual life of an instrument, </div><div id="a2902" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:55px;">that considers forecasts of future economic conditions in addition to information<div style="display:inline-block;width:5px"> </div>about past events and current conditions. ASU </div><div id="a2904" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:74px;">2016-13 requires new disclosures, including the use of vintage<div style="display:inline-block;width:5px"> </div>analysis on the Company’s credit quality indicators.<div style="display:inline-block;width:8px"> </div></div><div id="a2912" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:110px;">In addition, ASU 2016-13 removes the available-for-sale (“AFS”) securities other-than-temporary-impairment model that reduced </div><div id="a2930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:129px;">the cost basis of the investment and is replaced with an impairment model that<div style="display:inline-block;width:5px"> </div>will recognize an allowance for credit losses on </div><div id="a2932" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:147px;">available-for-sale securities.<div style="display:inline-block;width:4px"> </div></div><div id="a2939" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:184px;">Implementation</div><div id="a2940" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:95px;top:184px;"><div style="display:inline-block;width:3px"> </div>– The Company established a CECL committee to formulate and oversee the implementation process including </div><div id="a2944" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:199px;">selection, implementation, and testing of third-party software.<div style="display:inline-block;width:4px"> </div></div><div id="a2950" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:230px;">The Company used a loss-rate ("cohort") method to estimate the expected allowance<div style="display:inline-block;width:5px"> </div>for credit losses ("ACL") for all loan pools. </div><div id="a2958" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:248px;">The cohort method identifies and captures the balance of a pool of loans with similar<div style="display:inline-block;width:5px"> </div>risk characteristics, as of a particular point </div><div id="a2966" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:267px;">in time to form a cohort, then tracks the respective losses generated by that cohort of loans over<div style="display:inline-block;width:5px"> </div>their remaining lives, or until the </div><div id="a2973" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:285px;">loans are “exhausted” (i.e.; have reached an acceptable point in time at which<div style="display:inline-block;width:5px"> </div>a significant majority of all losses are </div><div id="a2978" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:304px;">expected to have been recognized). The cohort method closely aligned<div style="display:inline-block;width:5px"> </div>with the Company's incurred loss model. This allowed the </div><div id="a2987" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:322px;">Company to take advantages of the efficiencies of processes and procedures already<div style="display:inline-block;width:5px"> </div>in practice. </div><div id="a2995" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:359px;">The Company began parallel processing with the existing allowance for<div style="display:inline-block;width:5px"> </div>loan losses model during the first quarter of 2019 </div><div id="a2998" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:377px;">recalibrating inputs as necessary. The Company formulated changes to policies, procedures,<div style="display:inline-block;width:5px"> </div>disclosures, and internal controls that </div><div id="a3006" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:396px;">were necessary to transition to the new standard. A third-party completed validation of the completeness, accuracy, and </div><div id="a3020" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:414px;">reasonableness of the model in the fourth quarter of 2021. Refer to<div style="display:inline-block;width:5px"> </div>“Note 4: Loans and Allowance for Credit Losses (“ACL”)” for </div><div id="a3028" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:432px;">additional information regarding the policies, procedures, and credit<div style="display:inline-block;width:5px"> </div>quality indicators used by the Company. </div><div id="a3032" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:466px;">Impact of adoption</div><div id="a3033" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:113px;top:466px;"><div style="display:inline-block;width:3px"> </div>– The Company adopted ASU 2016-13 on January 1, 2022 using the modified retrospective approach. All </div><div id="a3039" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:485px;">disclosures as of and for the three-months ended March 31, 2022 are presented<div style="display:inline-block;width:5px"> </div>in accordance with ASC 326, Financial </div><div id="a3042" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:503px;">Instruments-Credit Losses. The Company did not recast comparative financial<div style="display:inline-block;width:5px"> </div>periods and has presented those disclosures under </div><div id="a3046" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:521px;">previously applicable GAAP. </div></div></div></div><div id="TextBlockContainer34" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:695px;height:181px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_30_XBRL_TS_4695c5c78bc046e2828f6d38a4186e84_1" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer31" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:695px;height:126px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3058" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:18px;">The Company used the prospective transition approach for AFS securities for which other-than-temporary-impairment<div style="display:inline-block;width:5px"> </div>has been </div><div id="a3068" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:37px;">recognized prior to January 1, 2022. As a result, the amortized cost basis remains the same before and after the effective date of </div><div id="a3070" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:55px;">ASU 2016-13.<div style="display:inline-block;width:4px"> </div></div><div id="a3075" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:92px;">Because the Company chose the cohort method, the model must consider<div style="display:inline-block;width:5px"> </div>net deferred fees and costs. As a result, the Company </div><div id="a3080" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:110px;">transferred the previously disclosed unearned fees into the applicable loan<div style="display:inline-block;width:5px"> </div>segments.</div></div></div><div id="div_32_XBRL_TS_045e94e636a04bcabb22c351e966cac4" style="position:absolute;left:0px;top:147px;float:left;"><div id="TextBlockContainer33" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:660px;height:34px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3084" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">The following table illustrates the impact of adopting ASU 2016-13 and details how outstanding loan balances have been </div><div id="a3087" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:18px;">reclassified because of changes made to the Company’s loan segments under<div style="display:inline-block;width:5px"> </div>CECL</div><div id="a3087_78_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:18px;">:</div></div></div></div><div id="TextBlockContainer41" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:707px;height:145px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3439" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">In connection with adoption of ASU 2016-13, changes were made to the Company’s loan segments to align with the methodology </div><div id="a3443" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:18px;">applied in determining the allowance under CECL. The commercial loan portfolio was separated<div style="display:inline-block;width:5px"> </div>into term loans and lines of </div><div id="a3445" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:37px;">credit. In addition, the remaining Paycheck Protection Program (“PPP”)<div style="display:inline-block;width:5px"> </div>loans were consolidated into the commercial term loan </div><div id="a3452" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:55px;">segment due to their declining outstanding balance. The Company also separated<div style="display:inline-block;width:5px"> </div>the residential and multifamily real estate loan </div><div id="a3457" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:74px;">segments. Refer to “Note 4: Loans and Allowance for Credit Losses (“ACL”)” for detail on the loan segments.<div style="display:inline-block;width:4px"> </div></div><div id="a3468" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:110px;">Accounting Policies:</div><div id="a3469" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:120px;top:110px;"><div style="display:inline-block;width:3px"> </div>The Company updated the below accounting policies due to adoption of ASU 2016-13: </div></div><div id="TextBlockContainer45" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:708px;height:494px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3484" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Accrued Interest - </div><div id="a3489" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:37px;">The Company made an accounting policy election to exclude accrued interest from<div style="display:inline-block;width:5px"> </div>the amortized cost basis of loans. In addition, </div><div id="a3491" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:55px;">the Company elected not to measure an allowance for credit losses for accrued<div style="display:inline-block;width:5px"> </div>interest receivable, because a timely write-off </div><div id="a3496" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:74px;">policy exists. The policy generally requires loans to be placed on nonaccrual<div style="display:inline-block;width:5px"> </div>when principal or interest is 90 days or more past </div><div id="a3498" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:92px;">due unless the loan is well-secured and in the process of collection. A well-secured loan means that collateral or a guaranty has </div><div id="a3506" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:110px;">sufficient value to pay off the loan in full. When a loan is placed on nonaccrual, accrued interest is reversed<div style="display:inline-block;width:5px"> </div>against interest </div><div id="a3511" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:129px;">income.<div style="display:inline-block;width:4px"> </div></div><div id="a3514" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:166px;">The Company made a policy election to exclude accrued interest from<div style="display:inline-block;width:5px"> </div>the amortized cost basis of AFS securities. AFS securities </div><div id="a3547" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:184px;">are placed on non-accrual status when the Company no longer expects<div style="display:inline-block;width:5px"> </div>to receive all contractual amounts due, which is generally </div><div id="a3556" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:202px;">at 90 days past due. Accrued interest receivable is reversed against interest income when a security is placed on nonaccrual<div style="display:inline-block;width:5px"> </div>status. </div><div id="a3558" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:221px;">Accordingly, the Company did not recognize an allowance for credit loss against<div style="display:inline-block;width:5px"> </div>accrued interest receivable.<div style="display:inline-block;width:4px"> </div></div><div id="a3568" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:258px;">Available-for-sale Securities in an Unrealized Loss Position –<div style="display:inline-block;width:2px"> </div></div><div id="a3580" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:294px;">For AFS securities in an unrealized loss position, the Company first assesses whether it intends to sell, or it is more<div style="display:inline-block;width:5px"> </div>likely than not </div><div id="a3585" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:313px;">that it will be required to sell the security before recovery of its amortized cost basis. If<div style="display:inline-block;width:5px"> </div>either of the criteria regarding<div style="display:inline-block;width:4px"> </div>intent or </div><div id="a3588" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:331px;">requirement to sell is met, the securities’ amortized cost basis is written down to fair value through income. For AFS securities </div><div id="a3590" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:350px;">that do not meet the criteria above, the Company evaluates whether the decline<div style="display:inline-block;width:5px"> </div>in fair value has resulted from credit losses or </div><div id="a3592" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:368px;">other factors. Management considers the extent to which fair value is less than amortized<div style="display:inline-block;width:5px"> </div>cost, any changes to the rating of the </div><div id="a3594" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:386px;">security by a rating agency, and adverse conditions specifically related to<div style="display:inline-block;width:5px"> </div>the security, among other factors.<div style="display:inline-block;width:4px"> </div></div><div id="a3597" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:423px;">If this assessment indicates that a credit loss exists, the present value of cash flows<div style="display:inline-block;width:5px"> </div>expected to be collected from the security is </div><div id="a3601" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:442px;">compared to the amortized cost basis of the security. If the present value of<div style="display:inline-block;width:5px"> </div>cash flows expected to be collected is less than the </div><div id="a3603" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:460px;">amortized cost basis, a credit loss exists and an allowance for credit losses is recorded<div style="display:inline-block;width:5px"> </div>for the credit loss, limited by the amount </div><div id="a3606" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:478px;">that the fair value is less than amortized cost basis.</div></div>
CY2022Q1	us-gaap	Debt Securities Available For Sale Maturity After One Through Five Years Weighted Average Yield DebtSecuritiesAvailableForSaleMaturityAfterOneThroughFiveYearsWeightedAverageYield	0.0415	pure
CY2022Q1	us-gaap	Debt Securities Available For Sale Maturity After Five Through Ten Years Weighted Average Yield DebtSecuritiesAvailableForSaleMaturityAfterFiveThroughTenYearsWeightedAverageYield	0.0332	pure
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	16828000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12035000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51657204	shares
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	16828000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	12035000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51657204	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	659193	shares
CY2021Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	724270	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50910490	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52381474	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	285672	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	669112	shares
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	752691000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	6987000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	36900000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	722778000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	716952000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	31568000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2551000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	745969000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	6000000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	741000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	5820000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis	99502000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling After Year Ten Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenAmortizedCostBasis	646628000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	752691000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	747000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	6009000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue	101783000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling After Year Ten Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenFairValue	614239000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	722778000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Maturity Within One Year Weighted Average Yield DebtSecuritiesAvailableForSaleMaturityWithinOneYearWeightedAverageYield	0.0349	pure
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	416996000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	36900000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	214	Securities
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	161024000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	2546000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Maturity After10 Years Weighted Average Yield DebtSecuritiesAvailableForSaleMaturityAfter10YearsWeightedAverageYield	0.0244	pure
CY2022Q1	us-gaap	Debt Securities Available For Sale Weighted Average Yield DebtSecuritiesAvailableForSaleWeightedAverageYield	0.0257	pure
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	374284000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	31918000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	199	Securities
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	42712000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	4982000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	15	Securities
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	57	Securities
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	1310000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	4	Securities
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	162334000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	2546000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	61	Securities
CY2022Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	USD
CY2022Q1	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	0	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	1000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Loss Excluding Other Than Temporary Impairment DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment	27000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-26000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	21000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Loss Excluding Other Than Temporary Impairment DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment	11000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	10000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-103000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-39000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-103000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-39000	USD
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	4256213000	USD
CY2022Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	4349568000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	55231000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	58375000	USD
CY2022Q1	us-gaap	Notes Receivable Net NotesReceivableNet	4294337000	USD
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	4197838000	USD
CY2022Q1	us-gaap	Financial Asset Amortized Cost Accrued Interest After Allowance For Credit Loss FinancialAssetAmortizedCostAccruedInterestAfterAllowanceForCreditLoss	10000000	USD
CY2021Q4	us-gaap	Financial Asset Amortized Cost Accrued Interest After Allowance For Credit Loss FinancialAssetAmortizedCostAccruedInterestAfterAllowanceForCreditLoss	10000000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	-3000000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	-3000000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	1000000	USD
CY2022Q1	us-gaap	Financing Receivable Originated In Current Fiscal Year FinancingReceivableOriginatedInCurrentFiscalYear	297233000	USD
CY2022Q1	us-gaap	Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear	1086026000	USD
CY2022Q1	us-gaap	Financing Receivable Originated Two Years Before Latest Fiscal Year FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear	574140000	USD
CY2022Q1	us-gaap	Financing Receivable Originated Three Years Before Latest Fiscal Year FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear	324390000	USD
CY2022Q1	us-gaap	Financing Receivable Originated Four Years Before Latest Fiscal Year FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear	231377000	USD
CY2022Q1	us-gaap	Financing Receivable Originated Five Or More Years Before Latest Fiscal Year FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear	179454000	USD
CY2022Q1	us-gaap	Financing Receivable Revolving FinancingReceivableRevolving	1452020000	USD
CY2022Q1	us-gaap	Financing Receivable Revolving Converted To Term Loan FinancingReceivableRevolvingConvertedToTermLoan	204928000	USD
CY2022Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	4349568000	USD
CY2022Q1	us-gaap	Financing Receivable Originated In Current Fiscal Year FinancingReceivableOriginatedInCurrentFiscalYear	297233000	USD
CY2022Q1	us-gaap	Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear	1086026000	USD
CY2022Q1	us-gaap	Financing Receivable Originated Two Years Before Latest Fiscal Year FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear	574140000	USD
CY2022Q1	us-gaap	Financing Receivable Originated Three Years Before Latest Fiscal Year FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear	324390000	USD
CY2022Q1	us-gaap	Financing Receivable Originated Four Years Before Latest Fiscal Year FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear	231377000	USD
CY2022Q1	us-gaap	Financing Receivable Originated Five Or More Years Before Latest Fiscal Year FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear	179454000	USD
CY2022Q1	us-gaap	Financing Receivable Revolving FinancingReceivableRevolving	1452020000	USD
CY2022Q1	us-gaap	Financing Receivable Revolving Converted To Term Loan FinancingReceivableRevolvingConvertedToTermLoan	204928000	USD
CY2022Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	4349568000	USD
CY2022Q1	us-gaap	Financing Receivable Nonaccrual Interest Income FinancingReceivableNonaccrualInterestIncome	1000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	58375000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	3612000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	2531000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	55231000	USD
CY2021Q4	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	0	USD
CY2022Q1	us-gaap	Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal	-309000	USD
CY2022Q1	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	4875000	USD
CY2022Q1	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	5000000	USD
CY2022Q1	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	0	USD
CY2021Q1	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	0	USD
CY2022Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	38000000	USD
CY2021Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	40000000	USD
CY2021Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	4269620000	USD
CY2021Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	4269620000	USD
CY2021Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	90000	USD
CY2021Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	31432000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	5597000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	52778000	USD
CY2021Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	58375000	USD
CY2021Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	56927000	USD
CY2021Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	4212693000	USD
CY2021Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	4269620000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	56927000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	67089000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	5597000	USD
CY2021Q1	cfb	Financing Receivable Impaired Interest Income FinancingReceivableImpairedInterestIncome	642000	USD
CY2021Q1	cfb	Financing Receivable Average Balance Of Impaired Loans FinancingReceivableAverageBalanceOfImpairedLoans	112000000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	75295000	USD
CY2021Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	7500000	USD
CY2021Q1	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	8266000	USD
CY2021Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	22000	USD
CY2021Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	74551000	USD
CY2022Q1	us-gaap	Time Deposit Maturities Next Rolling Twelve Months TimeDepositMaturitiesNextRollingTwelveMonths	445252000	USD
CY2022Q1	us-gaap	Time Deposit Maturities Rolling Year Two TimeDepositMaturitiesRollingYearTwo	54360000	USD
CY2022Q1	us-gaap	Time Deposit Maturities Rolling Year Three TimeDepositMaturitiesRollingYearThree	10248000	USD
CY2022Q1	us-gaap	Time Deposit Maturities Rolling Year Four TimeDepositMaturitiesRollingYearFour	1151000	USD
CY2022Q1	us-gaap	Time Deposit Maturities Rolling Year Five TimeDepositMaturitiesRollingYearFive	1056000	USD
CY2022Q1	us-gaap	Time Deposit Maturities After Rolling Year Five TimeDepositMaturitiesAfterRollingYearFive	0	USD
CY2022Q1	us-gaap	Time Deposits TimeDeposits	512067000	USD
CY2022Q1	us-gaap	Federal Home Loan Bank Advances Maturities Summary Due In Next Rolling Twelve Months FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths	11500000	USD
CY2022Q1	us-gaap	Federal Home Loan Bank Advances Maturities Summary Due In Rolling Year Two FederalHomeLoanBankAdvancesMaturitiesSummaryDueInRollingYearTwo	35000000	USD
CY2022Q1	us-gaap	Federal Home Loan Bank Advances Maturities Summary Due In Rolling Year Three FederalHomeLoanBankAdvancesMaturitiesSummaryDueInRollingYearThree	0	USD
CY2022Q1	us-gaap	Federal Home Loan Bank Advances Maturities Summary Due In Rolling Year Four FederalHomeLoanBankAdvancesMaturitiesSummaryDueInRollingYearFour	5100000	USD
CY2022Q1	us-gaap	Federal Home Loan Bank Advances Maturities Summary Due In Rolling Year Five FederalHomeLoanBankAdvancesMaturitiesSummaryDueInRollingYearFive	0	USD
CY2022Q1	us-gaap	Federal Home Loan Bank Advances Maturities Summary Due After Rolling Year Five FederalHomeLoanBankAdvancesMaturitiesSummaryDueAfterRollingYearFive	175000000	USD
CY2022Q1	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	226600000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	0	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	0	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	0	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	0	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	0	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive	1022000	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	1022000	USD
CY2022Q1	cfb	Time Deposit Maturities And Borrowings Next Rolling Twelve Months TimeDepositMaturitiesAndBorrowingsNextRollingTwelveMonths	456752000	USD
CY2022Q1	cfb	Time Deposit Maturities And Borrowings Rolling Year Two TimeDepositMaturitiesAndBorrowingsRollingYearTwo	89360000	USD
CY2022Q1	cfb	Time Deposit Maturities And Borrowings Rolling Year Three TimeDepositMaturitiesAndBorrowingsRollingYearThree	10248000	USD
CY2022Q1	cfb	Time Deposit Maturities And Borrowings Rolling Year Four TimeDepositMaturitiesAndBorrowingsRollingYearFour	6251000	USD
CY2022Q1	cfb	Time Deposit Maturities And Borrowings Rolling Year Five TimeDepositMaturitiesAndBorrowingsRollingYearFive	1056000	USD
CY2022Q1	cfb	Time Deposit Maturities And Borrowings After Rolling Year Five TimeDepositMaturitiesAndBorrowingsAfterRollingYearFive	176022000	USD
CY2022Q1	cfb	Time Deposit Maturities And Borrowings TimeDepositMaturitiesAndBorrowings	739689000	USD
CY2022Q1	cfb	Financial Instruments Subject To Mandatory Redemption Contract Value FinancialInstrumentsSubjectToMandatoryRedemptionContractValue	2600000	USD
CY2022Q1	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	644506000	USD
CY2021Q4	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.125	pure
CY2022Q1	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.116	pure
CY2022Q1	us-gaap	Tier One Leverage Capital Required For Capital Adequacy TierOneLeverageCapitalRequiredForCapitalAdequacy	222092000	USD
CY2021Q4	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy TierOneRiskBasedCapitalRequiredForCapitalAdequacy	440430000	USD
CY2021Q4	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.085	pure
CY2022Q1	cfb	Common Equity Tier One Capital Required For Capital Adequacy To Risk Weighted Assets CommonEquityTierOneCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.070	pure
CY2022Q1	us-gaap	Banking Regulation Capital Conservation Buffer Capital Conserved Minimum BankingRegulationCapitalConservationBufferCapitalConservedMinimum	0.025	pure
CY2022Q1	us-gaap	Capital Capital	704612000	USD
CY2022Q1	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.130	pure
CY2022Q1	us-gaap	Capital Required For Capital Adequacy CapitalRequiredForCapitalAdequacy	568675000	USD
CY2022Q1	us-gaap	Capital Required For Capital Adequacy To Risk Weighted Assets CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.105	pure
CY2022Q1	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	644506000	USD
CY2022Q1	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.119	pure
CY2022Q1	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy TierOneRiskBasedCapitalRequiredForCapitalAdequacy	460356000	USD
CY2022Q1	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.085	pure
CY2022Q1	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	643484000	USD
CY2022Q1	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	0.119	pure
CY2022Q1	us-gaap	Common Equity Tier One Capital Required For Capital Adequacy CommonEquityTierOneCapitalRequiredForCapitalAdequacy	379117000	USD
CY2022Q1	us-gaap	Tier One Leverage Capital Required For Capital Adequacy To Average Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets	0.040	pure
CY2021Q4	us-gaap	Capital Capital	704544000	USD
CY2021Q4	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.136	pure
CY2021Q4	us-gaap	Capital Required For Capital Adequacy CapitalRequiredForCapitalAdequacy	544060000	USD
CY2021Q4	us-gaap	Capital Required For Capital Adequacy To Risk Weighted Assets CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.105	pure
CY2021Q4	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	646169000	USD
CY2021Q4	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	645160000	USD
CY2021Q4	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	0.125	pure
CY2021Q4	us-gaap	Common Equity Tier One Capital Required For Capital Adequacy CommonEquityTierOneCapitalRequiredForCapitalAdequacy	362707000	USD
CY2021Q4	cfb	Common Equity Tier One Capital Required For Capital Adequacy To Risk Weighted Assets CommonEquityTierOneCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.070	pure
CY2021Q4	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	646169000	USD
CY2021Q4	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.118	pure
CY2021Q4	us-gaap	Tier One Leverage Capital Required For Capital Adequacy TierOneLeverageCapitalRequiredForCapitalAdequacy	218510000	USD
CY2021Q4	us-gaap	Tier One Leverage Capital Required For Capital Adequacy To Average Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets	0.040	pure
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1115000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	649000	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	4413000	USD
CY2021Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	3138000	USD
CY2022Q1	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	854000	USD
CY2021Q1	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	790000	USD
CY2022Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	82000	USD
CY2021Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	50000	USD
CY2022Q1	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	696000	USD
CY2021Q1	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	496000	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-169000	USD
CY2021Q1	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	14000	USD
CY2022Q1	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	20000	USD
CY2021Q1	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	2735000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	1653000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	2418000	USD
CY2022Q1	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	774000	USD
CY2021Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	1033000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	561000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2057000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	29021000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	26029000	USD
CY2022Q1	cfb	Deferred Tax Liabilities Unrealized Gains On Available For Sale Securities DeferredTaxLiabilitiesUnrealizedGainsOnAvailableForSaleSecurities	0	USD
CY2021Q4	cfb	Deferred Tax Liabilities Unrealized Gains On Available For Sale Securities DeferredTaxLiabilitiesUnrealizedGainsOnAvailableForSaleSecurities	6967000	USD
CY2022Q1	cfb	Deferred Tax Liabilities Federal Home Loan Bank Basis DeferredTaxLiabilitiesFederalHomeLoanBankBasis	689000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	6808000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	0	USD
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	14467000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	14051000	USD
CY2022Q1	cfb	Deferred Tax Assets Lease Incentive DeferredTaxAssetsLeaseIncentive	495000	USD
CY2021Q4	cfb	Deferred Tax Assets Lease Incentive DeferredTaxAssetsLeaseIncentive	508000	USD
CY2022Q1	cfb	Deferred Tax Assets Loan Fees DeferredTaxAssetsLoanFees	3190000	USD
CY2021Q4	cfb	Deferred Tax Assets Loan Fees DeferredTaxAssetsLoanFees	3227000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1073000	USD
CY2021Q4	cfb	Deferred Tax Liabilities Federal Home Loan Bank Basis DeferredTaxLiabilitiesFederalHomeLoanBankBasis	757000	USD
CY2022Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2470000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2602000	USD
CY2022Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	969000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1229000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4128000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	11555000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	24893000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	14474000	USD
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	726000	USD
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	213000	USD
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	5000	USD
CY2022Q1	us-gaap	Lease Cost LeaseCost	944000	USD
CY2022Q1	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Amount Liability FairValueDisclosureOffbalanceSheetRisksAmountLiability	2172934000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23000000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	26000000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y6M
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0190	pure
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2305000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3168000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2892000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2903000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2935000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	15509000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	29712000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4084000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	25628000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	743000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	33500	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.00
CY2022Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	33500	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	80000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	113500	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.00
CY2022Q1	cfb	Number Of Warrants Expire Next Fiscal Year NumberOfWarrantsExpireNextFiscalYear	80000	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.00

Files In Submission

Name	View Source	Status
0001562762-22-000212-index-headers.html	Edgar Link	pending
0001562762-22-000212-index.html	Edgar Link	pending
0001562762-22-000212.txt	Edgar Link	pending
0001562762-22-000212-xbrl.zip	Edgar Link	pending
cfb-20220331.htm	Edgar Link	pending
cfb-20220331.xsd	Edgar Link	pending
cfb-20220331_cal.xml	Edgar Link	unprocessable
cfb-20220331_def.xml	Edgar Link	unprocessable
cfb-20220331_htm.xml	Edgar Link	completed
cfb-20220331_lab.xml	Edgar Link	unprocessable
cfb-20220331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
q22021exhibit311.htm	Edgar Link	pending
q22021exhibit312.htm	Edgar Link	pending
q22021exhibit321.htm	Edgar Link	pending
q32021exhibit101.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CFB
CrossFirst Bankshares Inc Stock $cfb

2022 Q1 Form 10-Q Financial Statement

#000156276222000212 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CFB CrossFirst Bankshares Inc Stock $cfb

2022 Q1 Form 10-Q Financial Statement

#000156276222000212 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CFB
CrossFirst Bankshares Inc Stock $cfb